Literature DB >> 6139962

Cardiovascular effects of pancuronium and vecuronium during high-dose fentanyl anesthesia.

M Salmenperä, K Peltola, O Takkunen, J Heinonen.   

Abstract

To define the role of muscle relaxants in hemodynamic responses to high-dose (75 micrograms/kg) fentanyl anesthesia, we compared the circulatory effects of pancuronium (Pc) with those of vecuronium (Vc) in patients about to undergo coronary artery bypass surgery. The first measurements were made while the patients were awake. Thereafter the patients were anesthetized with fentanyl, intubated under succinylcholine relaxation and mechanically ventilated with a mixture of oxygen in air (FIO2 0.50). Ten minutes after completion of the fentanyl injection, the second set of measurements was made. Immediately thereafter, 0.1 mg/kg of either Pc (n = 10) or Vc (n = 10) was given, and no relaxant was administered to 10 control patients. Heart rate (HR) and cardiac index (CI), which had decreased significantly after fentanyl induction, decreased further after Vc, the latter decreases being significantly greater than the decreases in HR and CI observed in control patients. After Pc, HR and CI increased to control awake levels; rate-pressure product also increased and stroke index decreased. Five of ten patients receiving Vc had a HR below 45 beats/min; HRs this low were not seen in patients given Pc. Neither Pc nor Vc affected systemic vascular resistance, but filling pressures of the heart decreased abruptly after both relaxants. We conclude that if maintenance of preanesthetic hemodynamic status is the objective of anesthetic management of patients having coronary artery bypass surgery, Pc helps to achieve this objective during high-dose fentanyl anesthesia. On the other hand, many patients with limited coronary vascular reserve may well benefit from the negative chronotropic effect of Vc.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6139962

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  9 in total

1.  Vecuronium and danger of vagal induced cardiac arrest during laparotomy: a case report and literature review.

Authors:  A Stav; N Weksler; M Berman; L Ovadia; A Sternberg
Journal:  J Anesth       Date:  1992-07       Impact factor: 2.078

Review 2.  A simulation of neuromuscular function and heart rate during induction, maintenance, and reversal of neuromuscular blockade.

Authors:  R R Jaklitsch; D R Westenskow
Journal:  J Clin Monit       Date:  1990-01

3.  High-dose vecuronium neuromuscular block: a comparison of arrhythmias and onset of block during sufentanil anaesthesia.

Authors:  M D Sharpe; J M Murkin; T Vannelli
Journal:  Can J Anaesth       Date:  1995-08       Impact factor: 5.063

Review 4.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

Review 5.  Practical treatment recommendations for the safe use of anaesthetics.

Authors:  J W Sear
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

6.  Cardiovascular effects of non-depolarizing neuromuscular blockers in patients with aortic valve disease.

Authors:  D H Sethna; N J Starr; F G Estafanous
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

7.  A comparison of pipecuronium with pancuronium on haemodynamic variables and plasma catecholamines in coronary artery bypass patients.

Authors:  P P Neidhart; P Champion; J Vogel; E K Zsigmond; E Tassonyi
Journal:  Can J Anaesth       Date:  1994-06       Impact factor: 5.063

8.  Cardiovascular effects of non-depolarizing neuromuscular blockers in patients with coronary artery disease.

Authors:  D H Sethna; N J Starr; F G Estafanous
Journal:  Can Anaesth Soc J       Date:  1986-05

9.  Contribution of muscle relaxant to the haemodynamic course of high-dose fentanyl anaesthesia: a comparison of pancuronium, vecuronium and atracurium.

Authors:  J Heinonen; M Salmenperä; M Suomivuori
Journal:  Can Anaesth Soc J       Date:  1986-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.